You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycogen Storage Disease Type V

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pompe Disease -Non-invasive Magnetic Resonance Exploratory Pilot

Not yet recruiting
  • Pompe Disease
  • McArdle Disease
  • Siemens Magnetom 7T Plus
  • Vienna, Austria
    Medical University of Vienna
Jul 5, 2023

Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage

Recruiting
  • Glycogen Storage Disease
  • +2 more
  • No intervention
  • Copenhagen, Copenhange, Denmark
    Neuromuscular Research Unit, 8077
Oct 26, 2022

Glycogen Storage Disease Trial in Conegliano (Low carbohydrate ketogenic diet)

Completed
  • Glycogen Storage Disease
  • Low carbohydrate ketogenic diet
  • Conegliano, Treviso, Italy
    IRCCS Medea
Aug 25, 2021

Biomarker for Glycogen Storage Diseases (BioGlycogen)

Active, not recruiting
  • Fructose Metabolism, Inborn Errors
  • +9 more
    • Rostock, Germany
    • +3 more
    May 12, 2021

    McArdle Disease Trial in Madrid, London (REN001)

    Completed
    • McArdle Disease
    • Madrid, Spain
    • +1 more
    Jan 11, 2022

    Assess Exercise-induced Muscle Damage in Muscle Diseases

    Enrolling by invitation
    • Becker Muscular Dystrophy
    • +2 more
      • Copenhagen, Denmark
        Neuromuscular Research Unit, 3342
      Dec 17, 2021

      Ketogenic Diet Survey in Patients With McArdle Disease (GSDV)

      Not yet recruiting
      • McArdle Disease
      • There is no intervention, as this is a survey study
      • (no location specified)
      Jan 4, 2021

      Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))

      Not yet recruiting
      • Pompe Disease
      • +7 more
      • Multi-ingredient supplement (PDT-MIS)
      • Placebo (PLA)
      • (no location specified)
      Nov 8, 2023

      Biospecimen in Pediatric Patients and Adult Guardians Diagnosed

      Recruiting
      • Glycogen Storage Disease Type IB
      • Specimen Donation
      • Woburn, Massachusetts
        Sanguine BioSciences, Inc.
      Jun 22, 2023

      Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2 Trial in Worldwide (SPK-3006)

      Active, not recruiting
      • Pompe Disease
      • +6 more
      • SPK-3006
      • Phoenix, Arizona
      • +28 more
      Jul 22, 2022

      McArdle Disease Trial in Copenhagen (ß-hydroxybuturate esters, Placebo drink)

      Completed
      • McArdle Disease
      • β-hydroxybuturate esters
      • Placebo drink
      • Copenhagen, Denmark
        Copenhagen Neuromuscular Center
      Oct 5, 2020

      Long-Term Development of Muscular Dystrophy Outcome Assessments

      Not yet recruiting
      • LGMD1A
      • +33 more
        • Richmond, Virginia
          Virginia Commonwealth University
        Aug 3, 2023

        Glycogen Storage Disease VI, GLYCOGEN STORAGE DISEASE IXa1, GLYCOGEN STORAGE DISEASE IXa2 Trial in Durham (No intervention)

        Recruiting
        • Glycogen Storage Disease VI
        • +4 more
        • No intervention
        • Durham, North Carolina
          Duke University
        Jul 27, 2022

        Hypoglycemia in Glycogen Storage Disease Type III

        Recruiting
        • Glycogen Storage Disease Type III
        • No Intervention
        • Philadelphia, Pennsylvania
        • +1 more
        Jul 22, 2022

        Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Acid Maltase Deficiency Disease Trial in Gainesville, Decatur, Detroit

        Completed
        Has Results
        • Pompe Disease
        • +2 more
        • alglucosidase alfa
        • Gainesville, Florida
        • +2 more
        Jul 29, 2022

        Glycogen Storage Disease Type IV, Adult Polyglucosan Body Disease Trial in Durham (No intervention)

        Recruiting
        • Glycogen Storage Disease Type IV
        • Adult Polyglucosan Body Disease
        • No intervention
        • Durham, North Carolina
          Duke University Medical Center
        May 20, 2022

        Glycogen Storage Disease Trial in United States (mRNA-3745)

        Recruiting
        • Glycogen Storage Disease
        • Farmington, Connecticut
        • +4 more
        Jun 10, 2022

        Glycogen Storage Disease Type IB Trial in Shanghai (Empagliflozin)

        Recruiting
        • Glycogen Storage Disease Type IB
        • Shanghai, Shanghai, China
          Xinhua Hospital, Shanghai Jiao Tong University School of Medicin
        Jul 17, 2023

        Adeno-Associated Virus Antibody Study in Subjects OTC

        Recruiting
        • Ornithine Transcarbamylase Deficiency
        • +2 more
          • Akron, Ohio
          • +2 more
          Jul 22, 2022

          Glycogen Storage Disease Type II, Pompe Disease (Late-onset) Trial in Milan (Inspiratory Muscle Training (IMT), Inspiratory

          Recruiting
          • Glycogen Storage Disease Type II
          • Pompe Disease (Late-onset)
          • Inspiratory Muscle Training (IMT)
          • Inspiratory Muscle Training (IMT) + Air Stacking
          • Milan, Italy
            IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi
          Jul 11, 2023

          Glycogen Storage Disease Type III Trial in Worldwide (biological, other, drug)

          Recruiting
          • Glycogen Storage Disease Type III
          • UX053
          • +4 more
          • Orange, California
          • +9 more
          Jul 22, 2022

          Glycogen Storage Disease Type IA Trial in Groningen ([6,6-2H2]glucose)

          Completed
          • Glycogen Storage Disease Type IA
          • [6,6-2H2]glucose
          • Groningen, Netherlands
            University of Groningen, UMC Groningen
          Feb 10, 2022

          Glycogen Storage Disease Type IA Trial in Worldwide (genetic, other, drug)

          Recruiting
          • Glycogen Storage Disease Type IA
          • DTX401
          • +3 more
          • Orange, California
          • +16 more
          Jan 13, 2023

          GSD1 Trial in Worldwide (DTX401)

          Completed
          Has Results
          • GSD1
          • DTX401
          • steroid regimen
          • Farmington, Connecticut
          • +5 more
          Oct 25, 2022

          Pompe Disease (Late-onset) Trial (No Intervention)

          Not yet recruiting
          • Pompe Disease (Late-onset)
          • No Intervention
          • (no location specified)
          Nov 21, 2023